Secteur Trevi Therapeutics, Inc.

Actions

TRVI

US89532M1018

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 31/07/2026 Varia. 5j. Varia. 1 janv.
18,25 USD -0,82% Graphique intraday de Trevi Therapeutics, Inc. +4,08% +45,77%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
-0,82%+4,08%-2,14%+32,63%+45,77%+146,46%+666,81%+860,53% - 2,61 Md
+2,35%+0,77%+3,15%+17,23%+41,69%+29,92%+85,38%-14,38% - 55,23 Md
-0,21%-7,38%-8,18%+11,53%+3,93%+25,34%+63,02%+189,55%+5 743,14% 53,75 Md
-2,44%+1,40%-2,65%-12,44%-4,85%-15,74%-16,80%-72,41% - 23,48 Md
-2,85%-7,78%-7,52%-27,68%-43,35%-8,09%+346,36%+300,81%+761,14% 22 Md
+2,49%-0,92%+11,97%+17,25%+23,22%+20,31%-12,15%-67,31% - 19,78 Md
+0,79%-1,06%+3,54%+9,97%-8,31%+29,29%-33,32%-34,44%+54,10% 17,44 Md
+0,58%-5,88%+10,91%+3,07%+23,36%+16,30%+540,37% - - 14,66 Md
-5,25%-4,23%-2,54%+19,28%+20,99%+46,41%+169,05%+214,72%+477,67% 14,07 Md
+3,41%-7,83%-12,25%+77,89%+150,18%+161,76%+284,91%+1 349,84%+609,16% 13,02 Md
-3,06%-1,11%+3,85%+15,20%+27,50%+435,76%+145,22%+22,17%+1 320,30% 12,3 Md
-5,23%-14,18%-12,97%-9,68%-19,75%+54,48%+127,63%+435,18%+6 130,93% 11,37 Md
+0,80%-5,58%+6,70%-30,82%-16,86%-39,23%+128,87%+82,25% - 10,95 Md
-4,09%-4,47%-9,46%+20,57%+21,39%+104,91%+131,27%+159,87%+593,62% 10,92 Md
-3,12%-4,69%-10,64%-39,33%-25,56%-50,63%+520,00%+77,63%+86,00% 10,72 Md
+0,02%-.--%+0,37%+23,61%+23,23%+58,21%+148,67%+579,23% - 9,83 Md
-3,12%-3,72%+10,76%+32,08%+200,15%+479,43%+596,02%-35,84%-18,06% 8,93 Md
-0,13%-0,25%+123,20%+115,37%+79,42%+192,13%+339,58%+364,52% - 8,82 Md
+0,74%-.--%-.--%-.--%-.--%-.--%+46,98%+82,47% - 8,19 Md
-3,36%-1,06%-6,97%-5,52%+17,21%+59,29%+12,53%+149,45% - 8,08 Md
Moyenne -1,13%-2,58%+4,96%+13,51%+27,97%+87,32%+214,52%+244,41%+1 575,80% 16,81 Md
Moyenne pondérée par Capi. -0,53%-2,74%+1,93%+10,81%+21,47%+59,31%+155,22%+169,19%+2 488,29%
Médicaments bio-thérapeutiques
  1. Bourse
  2. Actions
  3. Action TRVI
  4. Secteur Trevi Therapeutics, Inc.